Kezar Life Sciences

Developer of drugs targeting protein homeostasis for autoimmune disorders

placeSan Francisco, California, United States calendar_todayFounded 2015 groups56 employees language kezarlifesciences.com

Registered entities

Innovation

12 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 819 times.

YearFilings
20182
20196
20208
20217
20227
20236
20247
20256
20261

Investor mix

17 investors on record; lead investors include EcoR1, Cormorant Asset Management, Solasta Ventures, Omega Funds.

Investor typeCountShare
Venture capital1165%
Private equity212%
Bank & private debt16%
Other / undisclosed318%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

16 Apr 2025 · Director Programming · South San Francisco

Based on job postings tracked across public sources.

Coming soon